Correlation Between Algorand and Lotus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Algorand and Lotus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algorand and Lotus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algorand and Lotus Pharmaceuticals, you can compare the effects of market volatilities on Algorand and Lotus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algorand with a short position of Lotus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algorand and Lotus Pharmaceuticals.

Diversification Opportunities for Algorand and Lotus Pharmaceuticals

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Algorand and Lotus is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Algorand and Lotus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lotus Pharmaceuticals and Algorand is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algorand are associated (or correlated) with Lotus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lotus Pharmaceuticals has no effect on the direction of Algorand i.e., Algorand and Lotus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Algorand and Lotus Pharmaceuticals

Assuming the 90 days trading horizon Algorand is expected to generate 4.85 times less return on investment than Lotus Pharmaceuticals. But when comparing it to its historical volatility, Algorand is 10.3 times less risky than Lotus Pharmaceuticals. It trades about 0.25 of its potential returns per unit of risk. Lotus Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.36  in Lotus Pharmaceuticals on October 26, 2024 and sell it today you would lose (0.03) from holding Lotus Pharmaceuticals or give up 8.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.41%
ValuesDaily Returns

Algorand  vs.  Lotus Pharmaceuticals

 Performance 
       Timeline  
Algorand 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Algorand are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Algorand exhibited solid returns over the last few months and may actually be approaching a breakup point.
Lotus Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lotus Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Lotus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Algorand and Lotus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Algorand and Lotus Pharmaceuticals

The main advantage of trading using opposite Algorand and Lotus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algorand position performs unexpectedly, Lotus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lotus Pharmaceuticals will offset losses from the drop in Lotus Pharmaceuticals' long position.
The idea behind Algorand and Lotus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios